Cargando…
Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?
Chronic calcium pyrophosphate crystal arthritis is a clinical consequence of the formation and deposition of these crystals in joints and can result in persistent arthritis. Curative treatment would require the removal of crystals from joints and tissues, but to date all agents tested have proven in...
Autores principales: | Pascual, Eliseo, Andrés, Mariano, Sivera, Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379613/ https://www.ncbi.nlm.nih.gov/pubmed/25885915 http://dx.doi.org/10.1186/s13075-015-0598-1 |
Ejemplares similares
-
15. A case of chronic polyarticular calcium pyrophosphate crystal inflammatory arthritis treated with subcutaneous methotrexate
por: Weightman, Jessica, et al.
Publicado: (2017) -
Imaging joints for calcium pyrophosphate crystal deposition: a knock to the knees
por: Terkeltaub, Robert
Publicado: (2012) -
Calcium pyrophosphate crystal size and characteristics
por: Zell, Monica, et al.
Publicado: (2021) -
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial
por: Finckh, Axel, et al.
Publicado: (2014) -
Calcium pyrophosphate crystal deposition disease: diagnosis and treatment
por: Rosales-Alexander, José Luis, et al.
Publicado: (2014)